Clinical Studies

Clinical Study

 Primary Investigator

Co-investigators

Evaluation of the veterinary peritoneal sepsis score as a model of risk stratification for dogs admitted with septic peritonitis;a multicenter study      


 Dr. Sue Casale

Dr. Megan Whelan
Dr. Rebecca Remillard

Biochemical markers of prognosis in canine traumatic brain injury (TB)


 Dr. Megan Whelan

 

The effects of hetastarch, human albumin and fresh frozen plasma on colloid osmotic pressure in critically ill dogs

   

 Dr. Adam Lancaster

Dr. Megan Whelan
Dr. Patty Ewing

Evaluation of ECG abnormalities in feline acute pancreatitis

 Dr. Rebecca Quinn

Dr. Nancy Laste
Dr. Rebecca Malakoff
Dr. Justin Williams

Red Cell Diameter Width as a Prognostic Indicator In Cats with Congestive Heart failures

 

 Dr. Kursten Roderick

 

Dr. Lindsey Nielsen
Dr. Rebecca Quinn

 

Use of topical ophthalmic 0.5% megestrol acetate for the treatment of eosinophilic (proliferative) keratitis in cats – pilot study

 

Dr. Martin Coster

 

 

Outcomes in dogs with uncomplicated pneumonia treated with short course vs. standard course antibiotics


Dr. Megan Davis
Dr. Annie Wayne

 

Prospective, multicenter, randomized, double-blind, placebo-controlled, 2 parallel groups, phase 3 study to compare efficacy and safety of masitinib to placebo in the treatment of grade 2 – 3 non-resectable mast cell tumors in dogs not previously treated by chemotherapy (other than corticosteroids) or radiotherapy.


 Dr. Carrie Wood

 

Post-chemotherapy perforation in cats with a clinical diagnosis of intermediate or high grade


 Dr.Zachary Crouse
 
Palatability study for new flea/tick product (Nexgard)
 Dr. Joel Kaye
 

Conformation & Cranial Cruciate Ligament Deficiency (CCLD) in Dogs


 Dr. Meghan Sullivan  

Retrospective study of albuterol toxicosis in dogs (2007 – 2014)  24 cases


 Dr. Roxanna Khorzad  
TPA in Acute Onset Feline Aortic Thromboembolism   Dr. Rebecca Quinn
Dr. Megan Whelan

A randomized, blind-controlled study to assess the clinical efficacy of SP-303 (crofelemer) in alleviating clinical signs associated with secretory diarrhea in dogs


Dr. Doug Brum
 
A Multicenter, Randomized, Placebo-Controlled Study of AT-005 in Combination with CCNU Chemotherapy in Treatment of Canine Intermediate to High Grade Peripheral T-Cell Lymphoma Dr. Carrie Wood Dr. Jennifer Mahoney; Dr. Ivan Martinez